School of Pharmacy introduces new interim dean

Carissa Haslam | Ad Manager 09/03/2020 After 30 years working in the School of Pharmacy, Dr. James Kirk Drennen stepped into the role of interim dean this summer with ease. Following Dr. J. Douglas Bricker’s final term as dean during the 2020 spring semester, the School of Pharmacy welcomed Dr. Drennen into his new position. Drennen himself is a product of Duquesne’s pharmacy program. He … Continue reading School of Pharmacy introduces new interim dean

Epilepsy drug linked to opioid misuse

Olivia Donia | Staff Writer 09/27/2018 A recent study conducted by Duquesne University professor John Tomko has linked high dosages of the epilepsy drug Gabapentin to opioid abuse. Based on the findings of the study, Tomko recommends prescribing and distributing Gabapentin with more scrutiny and oversight. Gabapentin, brand name Neurontin, has been formally approved by the Food and Drug Administration (FDA) to treat symptoms of … Continue reading Epilepsy drug linked to opioid misuse